PROMISE BIOTHERAPEUTICS Trademark
Trademark Overview
On Tuesday, April 30, 2024, a trademark application was filed for PROMISE BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROMISE BIOTHERAPEUTICS trademark a serial number of 98527302. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, November 19, 2024. This trademark is owned by Stealth BioTherapeutics Inc.. The PROMISE BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
General Information
| Serial Number | 98527302 |
| Word Mark | PROMISE BIOTHERAPEUTICS |
| Filing Date | Tuesday, April 30, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities |
| Goods and Services | Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Stealth BioTherapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Needham, MA 02494 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 30, 2024 | NEW APPLICATION ENTERED |
| Thursday, October 24, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 14, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, November 19, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 19, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
